13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001697013
申报总市值
US$19.3亿
US$19.3亿
70 檔
33.5%
在 Q1 2024 的 13F 官方备案中，Eversept Partners, LP 管理的美股投资组合规模来到 US$19.3亿，整体持股档数为 70 档。
在 Q1 2024，Eversept Partners, LP 操作展现出积极扩展与加仓意向。本季共新建仓 16 个新仓位，并对 13 个既有持股进行加仓（合计增持 29 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Eversept Partners, LP 的前 5 大核心持股（包含 NTRA, GSK, QQQ 等）合计占整体申报市值的 33.5%，反映机构在主要关键仓位上的权重分布。
本季最大新建仓标的
PFE
市值: US$3058.2万
本季最大获利了结 / 清仓标的
IMGNEUR
前期市值: US$2220.6万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | 股票-医疗保健 | 10.85% | -1.58% | -21.03% | |
| 2 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 10.79% | -3.89% | +26.88% | |
| 3 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 9.68% | -3.49% | +117.87% | |
| 4 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 6.03% | — | +19.82% | |
| 5 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 5.67% | — | -2.10% | |
| 6 | VERA | Vera Therapeutics Inc | 股票-其他 | 5.25% | +0.32% | -4.75% | |
| 7 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 4.97% | -0.38% | -7.39% | |
| 8 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 3.85% | -0.17% | +1.99% | |
| 9 | RVTY | Revvity Inc | 股票-医疗保健 | 3.38% | +0.09% | +163.94% | |
| 10 | TECH | Bio-techne CORP | 股票-医疗保健 | 2.85% | -0.28% | +30.60% | |
| 11 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 2.31% | +0.01% | -9.57% | |
| 12 | HQY | Healthequity Inc | 股票-医疗保健 | 2.29% | -0.23% | EXIT | |
| 13 | PFE | Pfizer Inc | 股票-医疗保健 | 2.04% | — | — | |
| 14 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.99% | +0.46% | -5.70% | |
| 15 | CYH | Community Health Systems Inc | 股票-其他 | 1.86% | +0.01% | +10.37% | |
| 16 | SWAVUSD | Shockwave Medical Inc | 股票-其他 | 1.75% | — | +6.24% | |
| 17 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 1.43% | — | -36.48% | |
| 18 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 1.23% | +0.82% | -6.21% | |
| 19 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 1.09% | +0.23% | +15.95% | |
| 20 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 1.06% | -3.67% | EXIT | |
| 21 | VTRS | Viatris Inc | 股票-医疗保健 | 1.05% | — | — | |
| 22 | PCVX | Vaxcyte Inc | 股票-其他 | 0.90% | -0.93% | -15.61% | |
| 23 | HUM | Humana Inc | 股票-医疗保健 | 0.82% | +0.64% | NEW | |
| 24 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 0.79% | +0.37% | NEW | |
| 25 | ✓ | Taro Pharmaceutical Inds LTD | 股票-其他 | 0.74% | — | +2.95% | |
| 26 | MNKD | Mannkind CORP | 股票-其他 | 0.72% | — | — | |
| 27 | DHR | Danaher CORP | 股票-医疗保健 | 0.68% | — | -0.45% | |
| 28 | LLY | Eli Lilly & Co | 股票-医疗保健 | 0.67% | +0.33% | — | |
| 29 | ZIMV | Zimvie Inc | 股票-其他 | 0.62% | — | +3.30% | |
| 30 | GH | Guardant Health Inc | 股票-医疗保健 | 0.62% | — | — | |
| 31 | BKD | Brookdale Senior Living Inc | 股票-其他 | 0.58% | +0.27% | — | |
| 32 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.56% | — | -5.46% | |
| 33 | IMVT | Immunovant Inc | 股票-其他 | 0.55% | — | +124.55% | |
| 34 | NVO | Novo-nordisk A/s-spons Adr | 股票-医疗保健 | 0.53% | +0.42% | NEW | |
| 35 | KPTIEUR | Karyopharm Therapeutics Inc | 股票-其他 | 0.51% | — | — | |
| 36 | PBYI | Puma Biotechnology Inc | 股票-其他 | 0.50% | — | -15.84% | |
| 37 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.50% | — | -4.64% | |
| 38 | TVTX | Travere Therapeutics Inc | 股票-其他 | 0.49% | +1.50% | — | |
| 39 | CNC | Centene CORP | 股票-医疗保健 | 0.49% | -0.19% | EXIT | |
| 40 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 0.49% | -0.56% | -6.32% | |
| 41 | GOSS | Gossamer Bio Inc | 股票-其他 | 0.47% | — | -6.81% | |
| 42 | TSHA | Taysha Gene Therapies Inc | 股票-其他 | 0.45% | — | -38.49% | |
| 43 | TSVT* | 2seventy Bio Inc | 股票-其他 | 0.42% | — | +3.39% | |
| 44 | STRO | Sutro Biopharma, Inc. | 股票-其他 | 0.41% | — | +3.31% | |
| 45 | LQDA | Liquidia CORP | 股票-其他 | 0.39% | +0.42% | -42.49% | |
| 46 | NVROEUR | Nevro CORP | 股票-其他 | 0.38% | — | — | |
| 47 | ✓ | Amarin Corp PLC | 股票-其他 | 0.37% | — | +1.92% | |
| 48 | ✓ | Merus N V | 股票-其他 | 0.36% | — | +3.25% | |
| 49 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 0.34% | -0.40% | EXIT | |
| 50 | WAT | Waters CORP | 股票-医疗保健 | 0.31% | — | -50.84% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | QQQ | Invesco Qqq Trust Series 1 | +4.3% | +117.87% | 加仓 |
| 2 | VERA | Vera Therapeutics Inc | +2.7% | -4.75% | 减仓 |
| 3 | PFE | Pfizer Inc | +2% | NEW | 新建仓 |
| 4 | RVTY | Revvity Inc | +1.6% | +163.94% | 加仓 |
| 5 | GSK | Gsk Plc-spon Adr | +1.1% | +26.88% | 加仓 |
| 6 | VTRS | Viatris Inc | +1.1% | NEW | 新建仓 |
| 7 | HUM | Humana Inc | +0.7% | +1756.43% | 加仓 |
| 8 | MNKD | Mannkind CORP | +0.7% | NEW | 新建仓 |
| 9 | LLY | Eli Lilly & Co | +0.7% | NEW | 新建仓 |
| 10 | GH | Guardant Health Inc | +0.6% | NEW | 新建仓 |
| 11 | BKD | Brookdale Senior Living Inc | +0.6% | NEW | 新建仓 |
| 12 | NVO | Novo-nordisk A/s-spons Adr | +0.5% | NEW | 新建仓 |
| 13 | KPTIEUR | Karyopharm Therapeutics Inc | +0.5% | NEW | 新建仓 |
| 14 | TVTX | Travere Therapeutics Inc | +0.5% | NEW | 新建仓 |
| 15 | SWAVUSD | Shockwave Medical Inc | +0.5% | +6.24% | 加仓 |
| 16 | NVROEUR | Nevro CORP | +0.4% | NEW | 新建仓 |
| 17 | STOK | Stoke Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 18 | CRBP | Corbus Pharmaceuticals Holdi | +0.2% | NEW | 新建仓 |
| 19 | ALEC | Alector Inc | +0.2% | NEW | 新建仓 |
| 20 | MOR2 | Morphosys AG Adr | +0.2% | NEW | 新建仓 |
| 21 | NAMS | NewAmsterdam Pharma Company N.V. | +0.2% | -5.46% | 减仓 |
| 22 | IMVT | Immunovant Inc | +0.1% | +124.55% | 加仓 |
| 23 | VKTX | Viking Therapeutics Inc | +0.1% | NEW | 新建仓 |
| 24 | 430 | Terns Pharmaceuticals Inc | +0.1% | NEW | 新建仓 |
| 25 | ✓ | Merus N V | +0.1% | +3.25% | 加仓 |
| 26 | TEVA | Teva Pharmaceutical-sp Adr | 0% | -2.10% | 减仓 |
| 27 | STRO | Sutro Biopharma, Inc. | 0% | +3.31% | 加仓 |
| 28 | THC | Tenet Healthcare CORP | 0% | -6.21% | 减仓 |
| 29 | TSVT* | 2seventy Bio Inc | 0% | +3.39% | 加仓 |
| 30 | GOSS | Gossamer Bio Inc | -0.1% | -6.81% | 减仓 |
| 31 | CYH | Community Health Systems Inc | -0.1% | +10.37% | 加仓 |
| 32 | MCRB1EUR | Seres Therapeutics Inc | -0.2% | -20.79% | 减仓 |
| 33 | INSP | Inspire Medical Systems Inc | -0.3% | +19.82% | 加仓 |
| 34 | BHVN | Biohaven Ltd. | -0.3% | EXIT | 清仓 |
| 35 | TECH | Bio-techne CORP | -0.3% | +30.60% | 加仓 |
| 36 | BCRX | Biocryst Pharmaceuticals Inc | -0.3% | -6.32% | 减仓 |
| 37 | LQDA | Liquidia CORP | -0.3% | -42.49% | 减仓 |
| 38 | PCVX | Vaxcyte Inc | -0.4% | -15.61% | 减仓 |
| 39 | HCA | Hca Healthcare Inc | -0.4% | -9.57% | 减仓 |
| 40 | A | Agilent Technologies Inc | -0.5% | EXIT | 清仓 |
| 41 | WAT | Waters CORP | -0.5% | -50.84% | 减仓 |
| 42 | HQY | Healthequity Inc | -0.6% | -14.87% | 减仓 |
| 43 | KRYS | Krystal Biotech Inc | -0.7% | -77.03% | 减仓 |
| 44 | UTHR | United Therapeutics CORP | -0.9% | +1.99% | 加仓 |
| 45 | ILMN | Illumina Inc | -1.1% | EXIT | 清仓 |
| 46 | ARGX | Argenx Se - Adr | -1.4% | -36.48% | 减仓 |
| 47 | SNDX | Syndax Pharmaceuticals Inc | -1.5% | -7.39% | 减仓 |
| 48 | NTRA | Natera Inc | -1.5% | -21.03% | 减仓 |
| 49 | IMGNEUR | Immunogen Inc | -2% | EXIT | 清仓 |
| 50 | SPY | Ss Spdr S&p 500 ETF Trust-us | -4% | -74.75% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，Eversept Partners, LP 在 Q1 2024 季度的美股持仓总市值约为 US$19.3亿，共申报了 70 个公开持股仓位。
在 Q1 2024 季度，Eversept Partners, LP 按市值排列的前三大核心持股分别为：NTRA (10.8%)、GSK (10.8%)、QQQ (9.7%)。其中最大持股仓位 NTRA 占据整体投资组合约 10.8% 的权重。
在 Q1 2024 季度中，Eversept Partners, LP 共进行了 50 项持仓异动，包含新建仓 16 个仓位、加仓 13 个仓位、减仓 17 个仓位以及清仓 4 个仓位。 其中最大新建仓标的为 PFE。 本季清仓仓位包含 IMGNEUR。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。